Confidia™ Health Institute
Plasntsville: 710 Main Street, Building 4, Plantsville, CT 06479
Bristol: 508 Birch Street, Bristol, CT 06010
Please Note: Below is an excerpt from an article from the Orthomolecular Medicine News Service.
OMNS Chinese edition editor Dr. Richard Cheng is reporting from China about the first approved study of 12,000 to 24,000 mg/day of vitamin C by IV. The doctor also specifically calls for immediate use of vitamin C for prevention of coronavirus (COVID-19).
A second clinical trial of intravenous vitamin C was announced in China on Feb. 13th. In this second study, says Dr. Cheng, "They plan to give 6,000 mg/day and 12,000 mg/day per day for moderate and severe cases. We are also communicating with other hospitals about starting more intravenous vitamin C clinical studies. We would like to see oral vitamin C included in these studies, as the oral forms can be applied to more patients and at home." Additional information at http://orthomolecular.org/resources/omns/v16n11.shtml
And on Feb 21, 2020, announcement has been made of a third research trial now approved for intravenous vitamin C for COVID-19. https://www.youtube.com/watch?v=VMDX0RSDp1k&feature=youtu.be
Dr. Cheng, who is a US board-certified specialist in anti-aging medicine, adds: "Vitamin C is very promising for prevention, and especially important to treat dying patients when there is no better treatment. Over 2,000 people have died of the COIV-19 outbreak and yet I have not seen or heard large dose intravenous vitamin C being used in any of the cases. The current sole focus on vaccine and specific antiviral drugs for epidemics is misplaced."
He adds that: "Early and sufficiently large doses of intravenous vitamin C are critical. Vitamin C is not only a prototypical antioxidant, but also involved in virus killing and prevention of viral replication. The significance of large dose intravenous vitamin C is not just at antiviral level. It is acute respiratory distress syndrome (ARDS) that kills most people from coronaviral pandemics (SARS, MERS and now NCP). ARDS is a common final pathway leading to death.
"We therefore call for a worldwide discussion and debate on this topic."
To read more from the Orthomolecular Medicine News Service article titled "Three Intravenous Vitamin C Research Studies Approved for Treating COVID-19" written by Editor Andrew W. Saul, click the button below!
Call (860) 378-2891 or fill out the form to start experiencing a new kind of primary care.
Our front desk will review your information.
A team member will contact you as soon as possible.
We will work with your schedule to set an appointment.
All information presented in this website is intended for informational purposes only. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.